NPI: 1912282369 · OREGON CITY, OR 97045 · Anesthesiology Physician · NPI assigned 10/18/2011
Authorized official ANDERSON, DONALD controls 20+ related entities in our dataset. Read more
| Authorized Official | ANDERSON, DONALD (ASSISTANT SECRETARY ENROLLMENTS) |
| NPI Enumeration Date | 10/18/2011 |
Other providers sharing the same authorized official: ANDERSON, DONALD
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 44,397 | $3.65M |
| 2019 | 39,157 | $2.93M |
| 2020 | 31,813 | $2.36M |
| 2021 | 28,501 | $1.97M |
| 2022 | 32,049 | $2.68M |
| 2023 | 37,027 | $3.02M |
| 2024 | 34,257 | $2.87M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 17,899 | 16,412 | $6.58M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 22,262 | 20,343 | $6.16M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 20,574 | 18,025 | $3.68M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 15,821 | 14,450 | $1.76M |
| 96375 | Therapeutic injection; each additional sequential IV push | 9,756 | 8,695 | $372K |
| 96361 | Intravenous infusion, hydration; each additional hour | 8,935 | 7,675 | $291K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 2,757 | 2,627 | $215K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1,537 | 1,197 | $112K |
| 71045 | Radiologic examination, chest; single view | 2,131 | 1,979 | $107K |
| 71046 | Radiologic examination, chest; 2 views | 1,699 | 1,546 | $54K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 222 | 151 | $46K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 165 | 156 | $34K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 196 | 181 | $25K |
| 70450 | Computed tomography, head or brain; without contrast material | 192 | 182 | $11K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1,075 | 1,036 | $8K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 84 | 79 | $8K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 62 | 62 | $6K |
| 80053 | Comprehensive metabolic panel | 34,136 | 30,954 | $4K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 36,180 | 32,678 | $4K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 28 | 28 | $1K |
| 83690 | 8,918 | 8,232 | $1K | |
| 84484 | 5,919 | 4,858 | $999.66 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 243 | 229 | $800.00 |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 96 | 88 | $674.00 |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 12,187 | 11,004 | $500.70 |
| 81025 | 1,445 | 1,318 | $458.40 | |
| 36415 | Collection of venous blood by venipuncture | 975 | 886 | $351.49 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 28 | 28 | $298.26 |
| 80305 | 535 | 439 | $266.00 | |
| 84145 | 1,782 | 1,671 | $241.99 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1,045 | 970 | $239.47 |
| 83605 | 1,445 | 1,274 | $184.73 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 130 | 88 | $148.00 |
| 81001 | 1,960 | 1,760 | $141.54 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 126 | 118 | $141.00 |
| J7030 | Infusion, normal saline solution , 1000 cc | 9,206 | 7,719 | $139.38 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 5,228 | 4,679 | $82.07 |
| 85610 | 967 | 887 | $75.16 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 5,916 | 5,187 | $52.45 |
| 81003 | 937 | 890 | $46.00 | |
| 84703 | 713 | 672 | $31.50 | |
| 84443 | Thyroid stimulating hormone (TSH) | 75 | 69 | $12.00 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 236 | 222 | $9.00 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 5,278 | 4,129 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1,309 | 1,252 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 1,006 | 891 | $0.00 |
| 87631 | 14 | 14 | $0.00 | |
| J1171 | Injection, hydromorphone, 0.1 mg | 61 | 54 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 2,105 | 1,651 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 947 | 723 | $0.00 |
| 96376 | 124 | 108 | $0.00 | |
| 80048 | Basic metabolic panel (calcium, ionized) | 55 | 51 | $0.00 |
| 83735 | 136 | 128 | $0.00 | |
| 83880 | 106 | 90 | $0.00 | |
| 87040 | 14 | 13 | $0.00 | |
| J2704 | Injection, propofol, 10 mg | 12 | 12 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 143 | 127 | $0.00 |
| 82803 | 14 | 13 | $0.00 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 16 | 16 | $0.00 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 14 | 14 | $0.00 |
| J8540 | Dexamethasone, oral, 0.25 mg | 24 | 13 | $0.00 |